Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1

Endocrine Practice

Volumn 17, Issue 4, 2011, Pages

  Ghazi, Ali A ^a   Dezfooli, Azizollah Abbasi ^b   Mohamadi, Farzaneh ^b   Yousefi, Seyed Vahid ^a   Amirbaigloo, Alireza ^a   Ghazi, Siavash ^a   Pourafkari, Marina ^c   Berney, Dan ^d   Ellard, Sian ^e   Grossman, Ashley B ^f  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d BARTS HEALTH NHS TRUST   (United Kingdom)

^e ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOTROPIN; HEPARIN; HYDROCORTISONE; INOTROPIC AGENT; KETOCONAZOLE;

ARTICLE; BLOOD SAMPLING; CARCINOID; CUSHING SYNDROME; DIABETES MELLITUS; GENE SEQUENCE; GIANT CELL GRANULOMA; HYPERTENSION; IRAN; JAW CANCER; MULTIPLE ENDOCRINE NEOPLASIA; MUSCLE WEAKNESS; NEPHROLITHIASIS; NEUROENDOCRINE TUMOR; PARATHYROID ADENOMA; PRIMARY HYPERPARATHYROIDISM; THYMOMA;

EID: 84860389931     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11038.CR     Document Type: Article

References (20)

1. Falchetti A, Marini F, Luzi E, et al. Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors. Genet Med. 2009;11:825-835.
2. Whitley SA, Moyes VJ, Park KM, et al. The appearance of the adrenal glands on computed tomography in multiple endocrine neoplasia type 1. Eur J Endocrinol. 2008;159: 819-824.
3. Takagi J, Otake K, Morishita M, et al. Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid. Intern Med. 2006;45:81-86. (Pubitemid 43291702)
4. Yano M, Fukai I, Kobayashi Y, et al. ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1. Ann Thorac Surg. 2006;81:366-368. (Pubitemid 41815450)
5. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954;16:363-371.
6. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the frst decade following identifcation of the gene. Hum Mutat. 2008;29:22-32.
7. Marini F, Falchetti A, Del Monte F, et al. Multiple endocrine neoplasia type 1. Orphanet J Rare Dis. 2006;1:38-46.
8. Sakurai A, Murakami A, Sano K, Uchino S, Fukushima Y. Unusual clinical and pathological presentation of a neu-roendocrine tumor in a patient with multiple endocrine neoplasia type 1. Endocr J. 2009;56:887-895.
9. Sugiura H, Morikawa T, Itoh K, et al. Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: report of a case. Surg Today. 2001;31:428-432. (Pubitemid 32441909)
10. de Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg. 2002;73:675-681. (Pubitemid 34117445)
11. Valli M, Fabris GA, Dewar A, et al. Atypical carcinoid tumour of the thymus: a study of eight cases. Histopathology. 1994;24:371-375. (Pubitemid 24193255)
12. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab. 2006;91:371-377. (Pubitemid 43236895)
13. Arora R, Gupta R, Sharma A, Dinda AK. Primary neuroendocrine carcinoma of thymus: a rare cause of Cushing's syndrome. Indian J Pathol Microbiol. 2010;53:148-151.
14. Moran CA, Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000;114:100-110. (Pubitemid 34453191)
15. Teh BT, Zedenius J, Kytölä S, et al. Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg. 1998;228: 99-105. (Pubitemid 30190322)
16. Ferolla P, Falchetti A, Filosso P, et al. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab. 2005;90:2603-2609. (Pubitemid 40686297)
17. Ghazi AA, Hosseinpanah F, M Ardakani E, Ghazi S, Hedayati M, Azizi F. Effects of different doses of oral cholecalciferol on serum 25(OH)D, PTH, calcium and bone markers during fall and winter in schoolchildren. Eur J Clin Nutr. 2010;64:1415-1422.
18. Mirsaeid Ghazi AA, Rais Zadeh F, Pezeshk P, Azizi F. Seasonal variation of serum 25 hydroxy D3 in residents of Tehran. J Endocrinol Invest. 2004;27:676-679. (Pubitemid 39359832)
19. Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol (Oxf). 1995;43:351-358.
20. Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J. Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg. 2001;88:708-714. (Pubitemid 34014642)